Showing 741 - 760 results of 971 for search '"Radiotherapy"', query time: 0.05s Refine Results
  1. 741

    Research Hotspots and Trends in Acupuncture for Cancer:A bibliometric analysis from 2004 to 2024 by Ji Z, Niu H, He A, Li K, Jia J, Zhang M, Liu G

    Published 2025-01-01
    “…Breast cancer is the type of cancer for which acupuncture is most commonly used.Conclusion: The future research focus will be on acupuncture as a treatment for sleep disorders, the alleviation of radiotherapy complications and the improvement of postoperative quality of life. …”
    Get full text
    Article
  2. 742

    Radiation Induces Pulmonary Fibrosis by Promoting the Fibrogenic Differentiation of Alveolar Stem Cells by Lu-Kai Wang, Tsai-Jung Wu, Ji-Hong Hong, Fang-Hsin Chen, John Yu, Chun-Chieh Wang

    Published 2020-01-01
    “…The lung is a radiosensitive organ, which imposes limits on the therapeutic dose in thoracic radiotherapy. Irradiated alveolar epithelial cells promote radiation-related pneumonitis and fibrosis. …”
    Get full text
    Article
  3. 743
  4. 744

    Desmoplastic Small Round Cell Tumor of Stomach by Ahmed Abu-Zaid, Ayman Azzam, Asma AlNajjar, Hussa Al-Hussaini, Tarek Amin

    Published 2013-01-01
    “…Patient received no postoperative radiotherapy or chemotherapy. A postoperative 3-month followup failed to show any recurrence. …”
    Get full text
    Article
  5. 745

    Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance by Alessia Fidoamore, Loredana Cristiano, Andrea Antonosante, Michele d’Angelo, Erica Di Giacomo, Carlo Astarita, Antonio Giordano, Rodolfo Ippoliti, Elisabetta Benedetti, Annamaria Cimini

    Published 2016-01-01
    “…This microenvironment helps GSCs to remain in a “quiescent” state preserving their potential to proliferate and differentiate, thus protecting them by the effects of chemo- and radiotherapy. Recent evidences suggest that responses of glioblastoma to standard therapies are determined by the microenvironment of the niche, where the GSCs reside, allowing a variety of mechanisms that contribute to the chemo- and radioresistance, by preserving GSCs. …”
    Get full text
    Article
  6. 746

    Evaluation of ior ® Leukocim efficacy on patients with Neutropenia. by Ana María Ramos Cedeño, Leslie Pérez Ruiz, Julio Dámaso Fernández Águila, Tamara Guerra, Maritza Cabrera Zamora, Hailen Bobillo López

    Published 2007-12-01
    “…</p><p><strong>Abstract</strong></p><p>To demonstrate the effectiveness of Leukocim an open, phase IV clinical trial was designed, 39 patients from Cienfuegos were evaluated with 73 neutropenic episodes in primary or secondary prophylaxis or treatment, the demographic parameters behaved with an age 49.86 year old average, the predominant sex was the feminine 64.38%, 73.97% belonged to the white race, when the effectiveness was analyzed we obtained that 46.5% received the treatment in an ambulatory way, whereas 52.1% was hospitalized; one patient abandoned before beginning the treatment, the 12,3% of patients abandoned the study, the dose number received in order to correction CAN was between 3 and 7, behaving with a stocking of 1.26 before receiving the treatment and of 5.82 after the same one receiving the next cycle chemo y/o radiotherapy in time demonstrating this way the effectiveness of the product.…”
    Get full text
    Article
  7. 747
  8. 748

    Pregnancy after Cancer Treatment and Pregnancy Associated Cancer: A Single Center Experience with 96 Cases by Mert Turğal, Kemal Beksaç, Derman Başaran, Aslıhan Yazıcıoğlu, Özgür Özyüncü, Ömer Aran, M. Sinan Beksaç

    Published 2015-08-01
    “…Patients were treated for their cancer with different modalities including surgery, chemotherapy and radiotherapy. We encountered maternal mortality in 8 cases, all occurred after delivery. …”
    Get full text
    Article
  9. 749

    Women's Quality of Life After Surgical Treatment for Breast Cancer by Daniel Alejandro Arroyo Zumarraga, Ximena Elizabeth Trujillo Romero, Miguel Ramos Argilagos

    Published 2023-10-01
    “…<strong>Foundation</strong>: breast cancer requires aggressive treatments such as mastectomy or lumpectomy, followed by radiotherapy or chemotherapy. These procedures can have physical, emotional and social consequences that affect women's quality of life. …”
    Get full text
    Article
  10. 750

    KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway by Yang Wang, Yue-ying Yang, Abulajiang Kamili, Dilimulati Aishanjiang, Yi Liu

    Published 2025-02-01
    “…KLF5/Keap1 regulates the effects of ESCC on in vivo radiotherapy. Conclusion KLF5 promotes ESCC radioresistance by inhibiting Keap1 transcription and activating the Nrf2 pathway.…”
    Get full text
    Article
  11. 751

    Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction by Laurence Moureau-Zabotto, Eric Teissier, Didier Cowen, David Azria, Steve Ellis, Michel Resbeut

    Published 2015-01-01
    “…Patients received primary external-beam radiotherapy with concurrent chemotherapy followed by surgical resection (Siewert I: upper oesogastrectomy; Siewert II/III: total gastrectomy with lower oesophagectomy). …”
    Get full text
    Article
  12. 752
  13. 753

    Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas by Arjen H. G. Cleven, Manon van Engeland, Bradly G. Wouters, Adriaan P. de Bruïne

    Published 2007-01-01
    “…Background: Hypoxia modifies the phenotype of tumors in a way that promotes tumor aggressiveness and resistance towards chemotherapy and radiotherapy. However, the expression and influence of hypoxia-regulated proteins on tumor biology are not well characterized in colorectal tumors. …”
    Get full text
    Article
  14. 754

    A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors by Xuemei Wang, Chi Yao, Li Quan, Junxiang Zhou

    Published 2025-02-01
    “…The treatment approach for LMD includes a combination of supportive care, surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, and intrathecal (IT) therapy, among other modalities. …”
    Get full text
    Article
  15. 755

    Tracheal adenoid cystic carcinoma presenting as a locally advanced thyroid gland carcinoma by Mariam Ben Ayed, MD, Makram Tbini, MD, Inès Riahi, MD, Sarra Idriss, MD, Mamia Ben Salah, MD

    Published 2025-03-01
    “…The tumor was judged as unresectable and the patient received radiotherapy and an endotracheal sent. After a follow-up period of 2 years, the tumor remained stable, and the patient receivedThis study aims to determine the clinical, radiological, and therapeutic aspects of advanced adenoid cystic carcinoma.…”
    Get full text
    Article
  16. 756

    Successful Use of a Multidisciplinary Approach to Treat a Perforated Duodenal Malignant Lymphoma in an Elderly Patient by Tomoko Takagishi, Yuta Niimi, Goshi Matsuki, Shinta Nagano, Junsuke Hinami, Masaaki Kajiwara, Kiyoshi Kaneko, Yoshihiro Kubota, Osamu Nakai

    Published 2018-01-01
    “…Residual lymphoma was treated with consolidation radiotherapy (50 Gy in 25 fractions) over 5 weeks after chemotherapy. …”
    Get full text
    Article
  17. 757

    Extensive Growth of an Anaplastic Meningioma by Hajrullah Ahmeti, Homajoun Maslehaty, Athanasios K. Petridis, Alexandros Doukas, Mehran Mahvash, Harald Barth, H. M. Mehdorn

    Published 2013-01-01
    “…With the presented case, we would like to show the aggressive behavior of anaplastic meningiomas in a very illustrative way. Chemotherapy, radiotherapy, and surgery reach their limits in this tumor entity.…”
    Get full text
    Article
  18. 758
  19. 759

    Establishment of a Risk Prediction Model for Pulmonary Infection in Patients with Advanced Cancer by Liangliang Yang, Xiaolong Xu, Qingquan Liu

    Published 2022-01-01
    “…Demographics, whether the primary cancer was lung cancer, lung metastasis, the pathological classification of lung cancer patients, the number of metastases, history of surgery, history of chemotherapy, history of radiotherapy, history of central venous catheterization, history of hypertension, diabetes, and whether with myelosuppression were recorded. …”
    Get full text
    Article
  20. 760

    Nanoparticles assisted drug delivery for effective management of Glioblastoma by Mansi Damani, Nagesh Nilawar, Munira Momin, Raghumani Singh Ningthoujham, Tabassum Khan

    Published 2025-01-01
    “…Standard treatments, including surgery, radiotherapy, and chemotherapy with temozolomide (TMZ), are often limited by the ability of the tumor to circumvent therapeutic effects and by the physiological barriers that restrict drug delivery to the brain parenchyma. …”
    Get full text
    Article